Showing 36,902 results

Filters
Human rights

Ugandan Health Officials Claim Human Rights Groups Are “Spoiling Our Response to HIV/AIDS”

Editor's pick
Box Turtle Bulletin
16 November 2011
HIV & criminal law

Punitive Economies: The Criminalization of HIV Transmission and Exposure in Europe

Editor's pick
Criminal HIV Transmission
16 November 2011
Vaginal rings & topical PrEP

First Combination ARV Vaginal Ring for HIV Prevention Being Tested in Phase I Safety Trial

Editor's pick
Microbicides Trials Network press release
15 November 2011
Money

HIV insurance needs still unmet

Editor's pick
FT Adviser
15 November 2011
Young people

UK: Relationships education still fails to reach most young people

Editor's pick
The Guardian
15 November 2011
HIV testing programmes & uptake

US: HIV-Related Measure Included Among New Leading Health Indicators

Editor's pick
Aids.gov
15 November 2011
Circumcision

Circumcision 'too Islamic' for Papuan Churches

Editor's pick
Jakarta Post
14 November 2011
Men who have sex with men (MSM)

Ugandan Gay Advocate’s Alleged Murderer Sentenced To 30 Years

Editor's pick
Box Turtle Bulletin
14 November 2011
Access to healthcare

Bristol-Myers Squibb Signs New Agreement to Expand Access to Reyataz® (atazanavir sulfate) in Brazil

Editor's pick
Bristol-Myers Squibb press release
14 November 2011
Access to healthcare

Public Health Groups Launch Global Campaign Against Abbott Labs’ Monopoly on Critical AIDS Medicine

Editor's pick
Public Citizen
10 November 2011
Drug-resistant TB

New Six-Way Agreement Among Pharmas and NGOs will Speed Development of TB Drug Combinations

Editor's pick
Critical Path to TB Drug Regimens
10 November 2011
HIV & criminal law

Western Cape Premier targets men who don’t use condoms

Editor's pick
Cape Argus
9 November 2011
New & experimental hepatitis C treatment

Transgene’s Therapeutic HCV Vaccine TG4040 Combined with Commonly Used Treatment Achieves Substantial Viral Suppression in Randomized Phase II trial

Editor's pick
Transgene press release
8 November 2011
New & experimental hepatitis C treatment

All-Oral Treatment Regimen of Bristol-Myers Squibb’s Investigational NS5A and NS3 Inhibitors Achieved 90% Sustained Virologic Response (SVR12) in Phase II Study Sentinel Cohort of Genotype 1b Null Responders

Editor's pick
Bristol-Myers Squibb press release
8 November 2011
New & experimental hepatitis C treatment

Interferon-free combination of BI 201335 plus BI 207127 and ribavirin shows up to 76% of patients achieve a virological response at week 12, and 59% achieve SVR12 with 16 weeks treatment

Editor's pick
Boehringer Ingelheim press release
8 November 2011
Undetectable viral load & treatment as prevention

Clinton to Urge Using Latest Science in New AIDS Push

Editor's pick
Wall Street Journal
8 November 2011
TB diagnosis

Tuberculosis breakthrough as scientists get funds for 'electronic nose'

Editor's pick
The Guardian
8 November 2011
Combatting stigma

Will This Generation's Magic Johnson Please Stand Up?

Editor's pick
The Body
7 November 2011
Global health initiatives

PEPFAR on sex workers: pesky cultural norms

Editor's pick
Epidreamiology
7 November 2011
Men who have sex with men (MSM)

Commonwealth summit failed LGBTI people

Editor's pick
Peter Tatchell Foundation
7 November 2011
New & experimental hepatitis C treatment

Novartis DEB025 data showed viral clearance as early as six weeks and potential for interferon-free therapy in hepatitis C patients

Editor's pick
Novartis (press release)
7 November 2011
New & experimental hepatitis C treatment

Positive Interim Data From a Phase 2 Study of INCIVEK(TM) (telaprevir) Combination Therapy in People Co-Infected with Hepatitis C and HIV Presented at The Liver Meeting(R)

Editor's pick
Vertex (press release)
7 November 2011
Combatting stigma

Magic Johnson remains a living symbol of hope

Editor's pick
Los Angeles Times
7 November 2011
PrEP

Responding to the AIDS Healthcare Foundation's arguments on test, treat and PrEP

Editor's pick
Bay Area Reporter
6 November 2011